Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

ColXα1 is a stromal component that colocalizes with elastin in the breast tumor extracellular matrix.

Wang Y, Lu S, Xiong J, Singh K, Hui Y, Zhao C, Brodsky AS, Yang D, Jolly G, Ouseph M, Schorl C, DeLellis RA, Resnick MB.

J Pathol Clin Res. 2019 Jan;5(1):40-52. doi: 10.1002/cjp2.115. Epub 2018 Nov 1.

2.

Stromal Clusterin Expression Predicts Therapeutic Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer.

Wang Y, Brodsky AS, Xiong J, Lopresti ML, Yang D, Resnick MB.

Clin Breast Cancer. 2018 Jun;18(3):e373-e379. doi: 10.1016/j.clbc.2017.08.007. Epub 2017 Aug 19.

PMID:
28890185
3.

Collagen type III α1 as a useful diagnostic immunohistochemical marker for fibroepithelial lesions of the breast.

Wang Y, Resnick MB, Lu S, Hui Y, Brodsky AS, Yang D, Yakirevich E, Wang L.

Hum Pathol. 2016 Nov;57:176-181. doi: 10.1016/j.humpath.2016.07.017. Epub 2016 Aug 3.

PMID:
27498063
4.

Fatty acid-binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon γ pathway.

Wood SM, Gill AJ, Brodsky AS, Lu S, Friedman K, Karashchuk G, Lombardo K, Yang D, Resnick MB.

Mod Pathol. 2017 Jan;30(1):123-133. doi: 10.1038/modpathol.2016.170. Epub 2016 Sep 30.

5.

TAF4b Regulates Oocyte-Specific Genes Essential for Meiosis.

Grive KJ, Gustafson EA, Seymour KA, Baddoo M, Schorl C, Golnoski K, Rajkovic A, Brodsky AS, Freiman RN.

PLoS Genet. 2016 Jun 24;12(6):e1006128. doi: 10.1371/journal.pgen.1006128. eCollection 2016 Jun.

6.

Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer.

Brodsky AS, Xiong J, Yang D, Schorl C, Fenton MA, Graves TA, Sikov WM, Resnick MB, Wang Y.

BMC Cancer. 2016 Apr 18;16:274. doi: 10.1186/s12885-016-2302-5.

7.

Cisplatin Resistant Spheroids Model Clinically Relevant Survival Mechanisms in Ovarian Tumors.

Chowanadisai W, Messerli SM, Miller DH, Medina JE, Hamilton JW, Messerli MA, Brodsky AS.

PLoS One. 2016 Mar 17;11(3):e0151089. doi: 10.1371/journal.pone.0151089. eCollection 2016.

8.

Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment.

Friedman K, Brodsky AS, Lu S, Wood S, Gill AJ, Lombardo K, Yang D, Resnick MB.

Mod Pathol. 2016 May;29(5):528-41. doi: 10.1038/modpathol.2016.54. Epub 2016 Mar 11.

9.

A Novel SDHA-deficient Renal Cell Carcinoma Revealed by Comprehensive Genomic Profiling.

Yakirevich E, Ali SM, Mega A, McMahon C, Brodsky AS, Ross JS, Allen J, Elvin JA, Safran H, Resnick MB.

Am J Surg Pathol. 2015 Jun;39(6):858-63. doi: 10.1097/PAS.0000000000000403.

PMID:
25724004
10.

Notch3 overexpression promotes anoikis resistance in epithelial ovarian cancer via upregulation of COL4A2.

Brown CW, Brodsky AS, Freiman RN.

Mol Cancer Res. 2015 Jan;13(1):78-85. doi: 10.1158/1541-7786.MCR-14-0334. Epub 2014 Aug 28.

11.

Oxysterols synergize with statins by inhibiting SREBP-2 in ovarian cancer cells.

Casella C, Miller DH, Lynch K, Brodsky AS.

Gynecol Oncol. 2014 Nov;135(2):333-41. doi: 10.1016/j.ygyno.2014.08.015. Epub 2014 Aug 16.

12.

Prognostic microRNA expression signature from examination of colorectal primary and metastatic tumors.

Ellermeier C, Vang S, Cleveland K, Durand W, Resnick MB, Brodsky AS.

Anticancer Res. 2014 Aug;34(8):3957-67.

PMID:
25075017
13.

Expression profiling of primary and metastatic ovarian tumors reveals differences indicative of aggressive disease.

Brodsky AS, Fischer A, Miller DH, Vang S, MacLaughlan S, Wu HT, Yu J, Steinhoff M, Collins C, Smith PJ, Raphael BJ, Brard L.

PLoS One. 2014 Apr 14;9(4):e94476. doi: 10.1371/journal.pone.0094476. eCollection 2014.

14.

CR1-mediated ATP release by human red blood cells promotes CR1 clustering and modulates the immune transfer process.

Melhorn MI, Brodsky AS, Estanislau J, Khoory JA, Illigens B, Hamachi I, Kurishita Y, Fraser AD, Nicholson-Weller A, Dolmatova E, Duffy HS, Ghiran IC.

J Biol Chem. 2013 Oct 25;288(43):31139-53. doi: 10.1074/jbc.M113.486035. Epub 2013 Sep 10.

15.

Identification of ovarian cancer metastatic miRNAs.

Vang S, Wu HT, Fischer A, Miller DH, MacLaughlan S, Douglass E, Comisar L, Steinhoff M, Collins C, Smith PJ, Brard L, Brodsky AS.

PLoS One. 2013;8(3):e58226. doi: 10.1371/journal.pone.0058226. Epub 2013 Mar 12. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/aeb6ccee-921a-4250-a18c-4ea633b984dd. Comisar, Lauren [added].

16.

MicroRNA profiling in mucosal biopsies of eosinophilic esophagitis patients pre and post treatment with steroids and relationship with mRNA targets.

Lu S, Mukkada VA, Mangray S, Cleveland K, Shillingford N, Schorl C, Brodsky AS, Resnick MB.

PLoS One. 2012;7(7):e40676. doi: 10.1371/journal.pone.0040676. Epub 2012 Jul 16.

17.

T0901317 inhibits cisplatin-induced apoptosis in ovarian cancer cells [corrected].

Miller DH, Fischer AK, Chu KF, Burr R, Hillenmeyer S, Brard L, Brodsky AS.

Int J Gynecol Cancer. 2011 Nov;21(8):1350-6. doi: 10.1097/IGC.0b013e318228f558. Erratum in: Int J Gynecol Cancer. 2011 Dec;21(9):1711.

18.

Integrated genomics of ovarian xenograft tumor progression and chemotherapy response.

Stuckey A, Fischer A, Miller DH, Hillenmeyer S, Kim KK, Ritz A, Singh RK, Raphael BJ, Brard L, Brodsky AS.

BMC Cancer. 2011 Jul 22;11:308. doi: 10.1186/1471-2407-11-308.

19.

Chromatin remodeling in the aging genome of Drosophila.

Wood JG, Hillenmeyer S, Lawrence C, Chang C, Hosier S, Lightfoot W, Mukherjee E, Jiang N, Schorl C, Brodsky AS, Neretti N, Helfand SL.

Aging Cell. 2010 Dec;9(6):971-8. doi: 10.1111/j.1474-9726.2010.00624.x. Epub 2010 Oct 21.

20.

Estrogen coordinates translation and transcription, revealing a role for NRSF in human breast cancer cells.

Bronson MW, Hillenmeyer S, Park RW, Brodsky AS.

Mol Endocrinol. 2010 Jun;24(6):1120-35. doi: 10.1210/me.2009-0436. Epub 2010 Apr 14. Erratum in: Mol Endocrinol. 2010 Aug;24(8):1694-5.

21.

Long-lived Indy induces reduced mitochondrial reactive oxygen species production and oxidative damage.

Neretti N, Wang PY, Brodsky AS, Nyguyen HH, White KP, Rogina B, Helfand SL.

Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2277-82. doi: 10.1073/pnas.0812484106. Epub 2009 Jan 21.

22.

Recent advances in RNA structure determination by NMR.

Hennig M, Williamson JR, Brodsky AS, Battiste JL.

Curr Protoc Nucleic Acid Chem. 2001 May;Chapter 7:Unit 7.7. doi: 10.1002/0471142700.nc0707s02. Review.

PMID:
18428875
23.

Exon expression profiling reveals stimulus-mediated exon use in neural cells.

McKee AE, Neretti N, Carvalho LE, Meyer CA, Fox EA, Brodsky AS, Silver PA.

Genome Biol. 2007;8(8):R159.

24.
25.

Genome-wide analysis of estrogen receptor binding sites.

Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton EK, Fertuck KC, Hall GF, Wang Q, Bekiranov S, Sementchenko V, Fox EA, Silver PA, Gingeras TR, Liu XS, Brown M.

Nat Genet. 2006 Nov;38(11):1289-97. Epub 2006 Oct 1.

PMID:
17013392
26.

Genomic localization of RNA binding proteins reveals links between pre-mRNA processing and transcription.

Swinburne IA, Meyer CA, Liu XS, Silver PA, Brodsky AS.

Genome Res. 2006 Jul;16(7):912-21. Epub 2006 Jun 12.

27.

Genomic mapping of RNA polymerase II reveals sites of co-transcriptional regulation in human cells.

Brodsky AS, Meyer CA, Swinburne IA, Hall G, Keenan BJ, Liu XS, Fox EA, Silver PA.

Genome Biol. 2005;6(8):R64. Epub 2005 Jul 15.

28.

Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1.

Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR, Fox EA, Silver PA, Brown M.

Cell. 2005 Jul 15;122(1):33-43.

29.

Analysis of RNA-protein interactions by flow cytometry.

Brodsky AS, Johnston AP, Trau M, Silver PA.

Curr Opin Mol Ther. 2003 Jun;5(3):235-40. Review.

PMID:
12870432
30.
31.

Identifying proteins that affect mRNA localization in living cells.

Brodsky AS, Silver PA.

Methods. 2002 Feb;26(2):151-5.

PMID:
12054891
32.

Base flexibility in HIV-2 TAR RNA mapped by solution (15)N, (13)C NMR relaxation.

Dayie KT, Brodsky AS, Williamson JR.

J Mol Biol. 2002 Mar 22;317(2):263-78.

PMID:
11902842
33.

Pre-mRNA processing factors are required for nuclear export.

Brodsky AS, Silver PA.

RNA. 2000 Dec;6(12):1737-49.

34.

Nuclear transport HEATs up.

Brodsky AS, Silver PA.

Nat Cell Biol. 1999 Jul;1(3):E66-7. No abstract available.

PMID:
10559913
35.

NMR evidence for a base triple in the HIV-2 TAR C-G.C+ mutant-argininamide complex.

Brodsky AS, Erlacher HA, Williamson JR.

Nucleic Acids Res. 1998 Apr 15;26(8):1991-5.

36.

Solution structure of the HIV-2 TAR-argininamide complex.

Brodsky AS, Williamson JR.

J Mol Biol. 1997 Apr 4;267(3):624-39.

PMID:
9126842

Supplemental Content

Loading ...
Support Center